BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38343517)

  • 21. dCROX and ROX Indices Predict Clinical Outcomes in Patients with COVID-19 Pneumonia Treated with High-Flow Nasal Cannula Oxygen Therapy.
    Ruchiwit P; Pongtongkam K; Saiphoklang N
    Crit Care Res Pract; 2024; 2024():8880259. PubMed ID: 38450049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19.
    Ait Hamou Z; Levy N; Charpentier J; Mira JP; Jamme M; Jozwiak M
    Respir Res; 2022 Dec; 23(1):329. PubMed ID: 36463161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of high-flow nasal cannula oxygen on patients with chronic obstructive pulmonary disease and mild hypercapnia: a retrospective cohort study based on the Medical Information Mart for Intensive Care-IV database].
    Liu T; Zhao Q; Shi Z; Du B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):686-691. PubMed ID: 34296687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation of the HACOR score and ROX index for predicting treatment failure in patients with coronavirus disease 2019 pneumonia managed on high-flow nasal cannula therapy: a multicenter retrospective observational study in Japan.
    Okano H; Yamamoto R; Iwasaki Y; Irimada D; Konno D; Tanaka T; Oishi T; Nawa H; Yano A; Taniguchi H; Otawara M; Matsuoka A; Yamauchi M
    J Intensive Care; 2024 Feb; 12(1):7. PubMed ID: 38360681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.
    Roca O; Messika J; Caralt B; García-de-Acilu M; Sztrymf B; Ricard JD; Masclans JR
    J Crit Care; 2016 Oct; 35():200-5. PubMed ID: 27481760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Use of the "Respiratory Rate Oxygenation (ROX) Index" in the Assessment of Respiratory Support and Observation of Its Outcome in COVID-19 Patients With Acute Respiratory Failure.
    Bhuiyan AT; Hossain M; Khan MJ; Hossain B; Sultana SA; Sharmin F; Akhtaruzzaman A
    Cureus; 2023 May; 15(5):e39529. PubMed ID: 37378178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of risk factors for the failure of respiratory support with high-flow nasal cannula oxygen therapy in children with acute respiratory dysfunction: A case-control study.
    Liu J; Li D; Luo L; Liu Z; Li X; Qiao L
    Front Pediatr; 2022; 10():979944. PubMed ID: 36081624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Retrospective Study on Experience of High-flow Nasal Cannula Oxygen in Critically Ill COVID-19 Adult Patients Admitted to Intensive Care Unit.
    Kerai S; Singh R; Saxena KN; Desai SD; Bhalotra AR
    Indian J Crit Care Med; 2022 Jan; 26(1):62-66. PubMed ID: 35110846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding the utility of the ROX index among patients with acute hypoxemic respiratory failure.
    Li A; Cove ME; Phua J; Puah SH; Ng V; Kansal A; Tan QL; Sahagun JT; Taculod J; Tan AY; Mukhopadhyay A; Tay CK; Ramanathan K; Chia YW; Sewa DW; Chew M; Lew SJW; Goh S; Dhanvijay S; Tan JJ; See KC;
    PLoS One; 2022; 17(4):e0261234. PubMed ID: 35472205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.
    Roca O; Caralt B; Messika J; Samper M; Sztrymf B; Hernández G; García-de-Acilu M; Frat JP; Masclans JR; Ricard JD
    Am J Respir Crit Care Med; 2019 Jun; 199(11):1368-1376. PubMed ID: 30576221
    [No Abstract]   [Full Text] [Related]  

  • 31. Retrospective evaluation of the respiratory rate-oxygenation index to predict the outcome of high-flow nasal cannula oxygen therapy in dogs (2018-2021): 81 cases.
    Eicher L; Young AA; Hoover L; Kuo KW; Her J
    J Vet Emerg Crit Care (San Antonio); 2024; 34(3):252-261. PubMed ID: 38708968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of ROX index in predicting the outcome of high flow nasal cannula: a systematic review and meta-analysis.
    Junhai Z; Jing Y; Beibei C; Li L
    Respir Res; 2022 Feb; 23(1):33. PubMed ID: 35177091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.
    Ferrer S; Sancho J; Bocigas I; Bures E; Mora H; Monclou E; Mulet A; Quezada A; Royo P; Signes-Costa J
    Respir Med; 2021; 189():106638. PubMed ID: 34634500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified Respiratory Rate Oxygenation Index: An Early Warning Index for the Need of Intubation in COVID-19 Patients with High-Flow Nasal Cannula Therapy.
    Ai T; Zhang Z; Tan Z; Shi Z; Li H; Zhang S; Zhao X; Yao Y; Li W; Gao Y; Zhu M
    J Emerg Med; 2023 Aug; 65(2):e93-e100. PubMed ID: 37479639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can the ROX index predict high-flow nasal cannula failure in children under 2 with lower respiratory tract infection?
    Vasquez-Hoyos P; Jacome-Orozco AL; Rodriguez-Mayorga AP; Sepulveda-Forero LE; Escobar-Serna DP; Barajas JS; Obando-Belalcazar E; Salinas-Jaimes CM; Peralta-Palmezano JJ; Jimenez-Chavez A; Camacho-Jimenez RE; Dominguez-Rojas JA
    Pediatr Pulmonol; 2024 May; 59(5):1246-1255. PubMed ID: 38305069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the ROX Index to Predict Treatment Outcome for High-Flow Nasal Cannula and/or Noninvasive Ventilation in Patients With COPD Exacerbations.
    Schaeffer BZ; Fazio SA; Stocking JC; Adams JY; Liu A; Black HB; Harper RW; Cortes-Puch I; Albertson TE; Kuhn BT
    Respir Care; 2024 Apr; ():. PubMed ID: 38653556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of High-Flow Nasal Cannula Oxygen Therapy in Patients with Mild Hypercapnia.
    Su L; Zhao Q; Liu T; Xu Y; Li W; Zhang A
    Lung; 2021 Oct; 199(5):447-456. PubMed ID: 34448939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Flow Nasal Cannula Treatment in Patients with COVID-19 Acute Hypoxemic Respiratory Failure: A Prospective Cohort Study.
    Alshahrani MS; Alshaqaq HM; Alhumaid J; Binammar AA; AlSalem KH; Alghamdi A; Abdulhady A; Yehia M; AlSulaibikh A; Al Jumaan M; Albuli WH; Ibrahim T; Yousef AA; Almubarak Y; Alhazzani W
    Saudi J Med Med Sci; 2021; 9(3):215-222. PubMed ID: 34667467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.
    Chandel A; Patolia S; Brown AW; Collins AC; Sahjwani D; Khangoora V; Cameron PC; Desai M; Kasarabada A; Kilcullen JK; Nathan SD; King CS
    Respir Care; 2021 Jun; 66(6):909-919. PubMed ID: 33328179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ROX (Respiratory rate-OXygenation) index to predict early response to high-flow nasal cannula therapy in infants with viral bronchiolitis.
    Milesi C; Nogue E; Baleine J; Moulis L; Pouyau R; Gavotto A; Brossier D; Mortamet G; Cambonie G;
    Pediatr Pulmonol; 2024 Apr; 59(4):982-990. PubMed ID: 38197495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.